New drug cocktail aims to shrink esophageal tumors before surgery
NCT ID NCT07490002
First seen Apr 11, 2026 · Last updated May 09, 2026 · Updated 2 times
Summary
This study tests whether giving three drugs (epacadostat, lenvatinib, and chemotherapy) before surgery can help eliminate or shrink esophageal cancer in 33 adults with stage II to IVa disease. The main goal is to see if the cancer completely disappears in the removed tissue. Participants must have resectable tumors and no distant spread.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.